NCT05130567View on ClinicalTrials.gov

A Study of LP-128 Capsules in Healthy Subjects

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

November 19, 2021

Primary Completion Date

September 30, 2026

Study Completion Date

December 30, 2026

Conditions
Chronic Hepatitis b
Interventions
DRUG

LP-128 capsules

Oral dosing with LP-128 capsules

OTHER

Matching Placebo

Oral dosing with placebo capsules to match LP-128 capsules.

Trial Locations (1)

510515

NanFang Hospital of Southern Medical University, Guangzhou

All Listed Sponsors
lead

Guangzhou Lupeng Pharmaceutical Company LTD.

INDUSTRY